Literature DB >> 11500393

Cellular mechanisms that cause suppressed gamma interferon secretion in endotoxin-tolerant mice.

T K Varma1, T E Toliver-Kinsky, C Y Lin, A P Koutrouvelis, J E Nichols, E R Sherwood.   

Abstract

Endotoxin (lipopolysaccharide [LPS]) tolerance is a state of altered immunity characterized, in part, by suppression of LPS-induced gamma interferon (IFN-gamma) expression. However, the cellular mediators regulating LPS-induced production of IFN-gamma in normal mice and the effect of LPS tolerance on these mediators has not been well characterized. Our studies show that macrophage dysfunction is the primary factor causing suppressed IFN-gamma expression in LPS-tolerant mice. Specifically, LPS-tolerant macrophages have a markedly impaired ability to induce IFN-gamma secretion by T cells and NK cells obtained from either control or LPS-tolerant mice. However, T cells and NK cells isolated from LPS-tolerant mice produce normal levels of IFN-gamma when cocultured with control macrophages or exogenous IFN-gamma-inducing factors. Assessment of important IFN-gamma-regulating factors showed that interleukin-12 (IL-12) and costimulatory signals provided by IL-15, IL-18, and CD86 are largely responsible for LPS-induced IFN-gamma expression in control mice. IL-10 is an inhibitor of IFN-gamma production in both the control and LPS-tolerant groups. Expression of IL-12 and the IL-12 receptor beta1 (IL-12Rbeta1) and IL-12Rbeta2 subunits are suppressed in the spleens of LPS-tolerant mice. LPS-tolerant splenocytes also exhibit decreased production of IL-15 and IL-15Ralpha. However, expression of IL-18 and the B7 proteins CD80 and CD86 are unchanged or increased compared to controls after induction of LPS tolerance. CD28, a major receptor for B7 proteins, is also increased in the spleens of LPS-tolerant mice. Expression of the inhibitory cytokine IL-10 and the IL-10R are sustained after induction of LPS tolerance. These data show that suppression of IFN-gamma production in LPS-tolerant mice is largely due to macrophage dysfunction and provide insight into the cellular alterations that occur in LPS tolerance. This study also better defines the factors that mediate LPS-induced IFN-gamma production in normal mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11500393      PMCID: PMC98633          DOI: 10.1128/IAI.69.9.5249-5263.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  IL-9 protects mice from Gram-negative bacterial shock: suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of IL-10.

Authors:  U Grohmann; J Van Snick; F Campanile; S Silla; A Giampietri; Carmine Vacca; J C Renauld; M C Fioretti; P Puccetti
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

2.  Cutting edge: IL-15 costimulates the generalized Shwartzman reaction and innate immune IFN-gamma production in vivo.

Authors:  T A Fehniger; H Yu; M A Cooper; K Suzuki; M H Shah; M A Caligiuri
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

3.  IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells.

Authors:  K Tominaga; T Yoshimoto; K Torigoe; M Kurimoto; K Matsui; T Hada; H Okamura; K Nakanishi
Journal:  Int Immunol       Date:  2000-02       Impact factor: 4.823

4.  IFN-gamma-dependent and -independent mechanisms in adverse effects caused by concomitant administration of IL-18 and IL-12.

Authors:  S Nakamura; T Otani; Y Ijiri; R Motoda; M Kurimoto; K Orita
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

5.  Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.

Authors:  B R Lauwerys; J C Renauld; F A Houssiau
Journal:  Cytokine       Date:  1999-11       Impact factor: 3.861

6.  TCR and IL-12 receptor signals cooperate to activate an individual response element in the IFN-gamma promoter in effector Th cells.

Authors:  F Zhang; T Nakamura; T M Aune
Journal:  J Immunol       Date:  1999-07-15       Impact factor: 5.422

7.  Injury induces deficient interleukin-12 production, but interleukin-12 therapy after injury restores resistance to infection.

Authors:  A Göebel; E Kavanagh; A Lyons; I B Saporoschetz; C Soberg; J A Lederer; J A Mannick; M L Rodrick
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

8.  Reduced Th1, but not Th2, cytokine production by lymphocytes after in vivo exposure of healthy subjects to endotoxin.

Authors:  F N Lauw; T ten Hove; P E Dekkers; E de Jonge; S J van Deventer; T van Der Poll
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

9.  Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression.

Authors:  F Nomura; S Akashi; Y Sakao; S Sato; T Kawai; M Matsumoto; K Nakanishi; M Kimoto; K Miyake; K Takeda; S Akira
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

10.  Translocation of endotoxin and acute-phase proteins in malleolar fractures.

Authors:  K Buttenschoen; W Fleischmann; U Haupt; L Kinzl; D C Buttenschoen
Journal:  J Trauma       Date:  2000-02
View more
  20 in total

1.  The effects of repeated endotoxin exposure on rat brain metabolites as measured by ex vivo 1HMRS.

Authors:  Sulie L Chang; Christine C Cloak; Lorenc Malellari; Linda Chang
Journal:  J Neuroimmunol       Date:  2005-09       Impact factor: 3.478

2.  Cysteinyl-glycine reduces mucosal proinflammatory cytokine response to fMLP in a parenterally-fed piglet model.

Authors:  Matthew G Nosworthy; Janet A Brunton
Journal:  Pediatr Res       Date:  2016-04-07       Impact factor: 3.756

3.  Endotoxin-induced gamma interferon production: contributing cell types and key regulatory factors.

Authors:  Tushar K Varma; Cheng Y Lin; Tracy E Toliver-Kinsky; Edward R Sherwood
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

4.  Endotoxin priming improves clearance of Pseudomonas aeruginosa in wild-type and interleukin-10 knockout mice.

Authors:  Tushar K Varma; Megan Durham; Erle D Murphey; Weihua Cui; Zhiyu Huang; Cheng Y Lin; Tracy Toliver-Kinsky; Edward R Sherwood
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

5.  PEG-rIL-10 treatment decreases FoxP3(+) Tregs despite upregulation of intratumoral IDO.

Authors:  Ivan H Chan; Victoria Wu; Melissa Bilardello; Brett Jorgenson; Harminder Bal; Scott McCauley; Peter Van Vlasselaer; John B Mumm
Journal:  Oncoimmunology       Date:  2016-06-27       Impact factor: 8.110

Review 6.  The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants.

Authors:  Julia K Bohannon; Antonio Hernandez; Perenlei Enkhbaatar; William L Adams; Edward R Sherwood
Journal:  Shock       Date:  2013-12       Impact factor: 3.454

7.  Monophosphoryl Lipid a Attenuates Multiorgan Dysfunction During Post-Burn Pseudomonas Aeruginosa Pneumonia in Sheep.

Authors:  Satoshi Fukuda; Koji Ihara; Julia K Bohannon; Antonio Hernandez; Naeem K Patil; Liming Luan; Cody Stothers; Ryan Stark; Donald S Prough; David N Herndon; Edward R Sherwood; Perenlei Enkhbaatar
Journal:  Shock       Date:  2020-03       Impact factor: 3.533

8.  Chronic brucellosis patients retain low frequency of CD4+ T-lymphocytes expressing CD25 and CD28 after Escherichia coli LPS stimulation of PHA-cultured PBMCs.

Authors:  Panagiotis Skendros; Alexandros Sarantopoulos; Konstantinos Tselios; Panagiota Boura
Journal:  Clin Dev Immunol       Date:  2009-01-25

9.  MiR-146b Mediates Endotoxin Tolerance in Human Phagocytes.

Authors:  Tiziana Ada Renzi; Marcello Rubino; Laura Gornati; Cecilia Garlanda; Massimo Locati; Graziella Curtale
Journal:  Mediators Inflamm       Date:  2015-09-14       Impact factor: 4.711

10.  A Glucuronoxylomannan-Associated Immune Signature, Characterized by Monocyte Deactivation and an Increased Interleukin 10 Level, Is a Predictor of Death in Cryptococcal Meningitis.

Authors:  James E Scriven; Lisa M Graham; Charlotte Schutz; Thomas J Scriba; Katalin A Wilkinson; Robert J Wilkinson; David R Boulware; Britta C Urban; David G Lalloo; Graeme Meintjes
Journal:  J Infect Dis       Date:  2016-01-14       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.